Results 11 to 20 of about 174,408 (264)

COVID-19 Booster Vaccines Administration in Different Countries

open access: yesProgress in Microbes and Molecular Biology, 2021
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus
Angel Yun-Kuan Thye   +3 more
doaj   +1 more source

Efficacy of COVID-19 vaccines

open access: yesMicrobial Pathogenesis, 2022
As of 2022, the global population has access to several mRNA and traditional inactivated vaccines. However, their effectiveness in preventing infection, hospitalization, and COVID-associated mortality in Jordan has yet to be evaluated. The purpose of this observational study was to evaluate the relative effectiveness of three approved vaccines against ...
Mohamed J. Saadh, Saif Aldeen Jaber
openaire   +2 more sources

COVID-19 Vaccination and The Eye [PDF]

open access: yesAmerican Journal of Ophthalmology, 2022
To summarize the current evidence on COVID-19 vaccine-associated ocular adverse events.Narrative literature review.The literature search was conducted in August 2021 using 4 electronic databases: MEDLINE, EMBASE, PubMed, and the Cochrane Database of Systematic Reviews.
Michael T.M. Wang   +3 more
openaire   +2 more sources

The Time for COVID-19 Vaccination

open access: yesJournal of Virology, 2021
The composition and dynamics of viral mutant spectra in infected individuals advise that to avoid selection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape mutants, vaccination campaigns for coronavirus disease 2019 (COVID-19) should be launched when disease incidence is low.
Domingo, Esteban, Perales, Celia
openaire   +4 more sources

Dermatological Complications of COVID 19 Vaccines: An Updated Review

open access: yesNational Journal of Community Medicine, 2023
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the 2019 coronavirus disease (COVID-19) pandemic, have been rapidly developed and authorized.
Mohammed Omar Alsadi, Vinita John
doaj   +1 more source

COVID‐19: vaccine’s progress [PDF]

open access: yesMicrobial Biotechnology, 2021
Summary Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed. What normally takes a decade was worked out within a year. Vaccines were produced along many different platforms ranging from inactivated whole virus vaccines over adenovirus‐vectored ...
openaire   +4 more sources

SOCIAL REPRESENTATIONS ON VACCINES AND VACCINATION AGAINST COVID 19

open access: yesRevista Científica Arbitrada de la Fundación MenteClara, 2021
The representations are described as a specific style of knowledge, a specific way of deciphering reality, alluding to common sense thinking, being associated with a personal development that involves cognitive ordering and at the same time finds its ...
Valeria Fernanda Altamirano   +20 more
doaj   +1 more source

How can COVID-19 vaccines benefit people? A study based on the theory of the commons

open access: yesHuman Vaccines & Immunotherapeutics, 2023
COVID−19 vaccination is a fundamental step toward controlling the COVID−19 pandemic and defusing the public health crisis it has caused. Existing studies have demonstrated that equitable distribution of COVID−19 vaccines can only be achieved if these ...
Yiqing Su   +3 more
doaj   +1 more source

The Willingness of Elderly Taiwanese Individuals to Accept COVID-19 Vaccines after the First Local Outbreak

open access: yesVaccines, 2022
Vaccination is the most effective intervention to prevent infection and subsequent complications from SARS-CoV-2. Because of their multiple comorbidities, the elderly population experienced the highest number of deaths from the COVID-19 pandemic ...
Chia-Yu Huang   +8 more
doaj   +1 more source

COVID-19 Vaccine Development to Vaccination

open access: yesJournal of Nepal Health Research Council, 2021
In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine ...
Ashok Pandey   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy